secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0000950170-24-060049
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Q1 revenue $2.2M; OvaWatch volume up 114% YoY
----------------------------------------------------

- Product revenue $2.2M, down 4% YoY; OvaSuite volume 5,829 units (-7%).
- Gross profit margin improved to 56% from 51% in Q1 2023.
- Cash used in operating activities $4.4M, down 22% YoY; 2024 target stays $15-18M.
- OvaWatch volume grew 114% YoY; longitudinal monitoring feature launched.
- New Anthem Blue Cross CA coverage agreement for OvaSuite effective June 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000095017024060049/0000950170-24-060049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000095017024060049/awh-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-060049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer